Oragenics Inc. (OGEN)
Oragenics Statistics
Share Statistics
Oragenics has 21.48M shares outstanding. The number of shares has increased by 284.81% in one year.
| Shares Outstanding | 21.48M |
| Shares Change (YoY) | 284.81% |
| Shares Change (QoQ) | 70.84% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 17.11M |
| Failed to Deliver (FTD) Shares | 11.84K |
| FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 136K, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 136K |
| Short % of Shares Out | 0.63% |
| Short % of Float | 0.65% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.23 and the forward PE ratio is -0.49. Oragenics's PEG ratio is 0.
| PE Ratio | -0.23 |
| Forward PE | -0.49 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | -11.54 |
| P/FCF Ratio | -0.28 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Oragenics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of -1.55.
| Current Ratio | 0.87 |
| Quick Ratio | 0.87 |
| Debt / Equity | -1.55 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.04 |
| Interest Coverage | 353.99 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-3.52M |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -84.96% in the last 52 weeks. The beta is 0.87, so Oragenics's price volatility has been higher than the market average.
| Beta | 0.87 |
| 52-Week Price Change | -84.96% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.5 |
| Relative Strength Index (RSI) | 30.88 |
| Average Volume (20 Days) | 4.96M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -10.56M |
| Net Income | -10.57M |
| EBITDA | -10.56M |
| EBIT | -10.6M |
| Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has 864.84K in cash and 328.53K in debt, giving a net cash position of 536.31K.
| Cash & Cash Equivalents | 864.84K |
| Total Debt | 328.53K |
| Net Cash | 536.31K |
| Retained Earnings | -216.79M |
| Total Assets | 1.47M |
| Working Capital | -211.88K |
Cash Flow
In the last 12 months, operating cash flow was -8.6M and capital expenditures 0, giving a free cash flow of -8.6M.
| Operating Cash Flow | -8.6M |
| Capital Expenditures | 0 |
| Free Cash Flow | -8.6M |
| FCF Per Share | -1.3 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OGEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for OGEN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 23, 2023. It was a backward split with a ratio of 1:60.
| Last Split Date | Jan 23, 2023 |
| Split Type | backward |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | -228.43 |
| Piotroski F-Score | 2 |